Publications by authors named "Chu Lin"

Claim this Profile
A
Anti-diabetic medications and cancer: links beyond glycemic and body weight control.
Meng Cao, Chu Lin, Xiaoling Cai, Fang Lv, Wenjia Yang, Linong Ji

Precis Clin Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive blood pressure reduction but an increased risk of peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials.
Ruoyang Jiao, Chu Lin, Zonglin Li, Xingyun Zhu, Xiaoling Cai, Linong Ji

Ann Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional, age-specific and sex-specific trends in the prevalence of overweight or obesity in type 1 diabetes from 1980 to 2020: a meta-analysis of 78 observational studies with 650,265 participants.
Yuchen Guo, Chu Lin, Xiaoling Cai, Han Wu, Jingya Yan, Zonglin Li, Linong Ji

Diabetes Res Clin Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight Loss, Obesity Medication, and Risk of Obesity-Associated Cancer: A Meta-Analysis of Randomized Controlled Trials.
Chengwen Li, Chu Lin, Xiaoling Cai, Fang Lv, Wenjia Yang, Linong Ji

Obesity (Silver Spring)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide-1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesity.
Jingxuan Wang, Chu Lin, Xiaoling Cai, Yiran Wang, Tingyang Wei, Linong Ji

Diabetes Obes Metab· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing echocardiographic abnormalities and their associated factors in patients with type 1 diabetes: a cross-sectional study.
Wenfeng Yang, Chu Lin, Xiaoling Cai, Zonglin Li, Fang Lv, Geling Liu, Xiaolin Yang, Linong Ji

Cardiovasc Diabetol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular and brain effects of liraglutide in transthyretin amyloidosis (ATTR) mice models.
Mengqing Zhang, Zonglin Li, Xiaoling Cai, Fang Lv, Xin Wen, Chu Lin, Linong Ji

Int J Med Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Contributions of Risk Factor Modifications to the Reduction of Cardiovascular Risk in Patients With Antidiabetic Treatment: A Meta-Regression Analysis and Model-Based Analysis.
Xingyun Zhu, Chu Lin, Zonglin Li, Xiaoling Cai, Fang Lv, Linong Ji

Diabetes Metab Res Rev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCSK9 Inhibitor and Potential Decreased Risk of Neoplasms, Especially in Females: A Meta-Analysis.
Tingyang Wei, Zonglin Li, Chu Lin, Yuteng Yang, Changjie Tie, Xiaoling Cai, Linong Ji

Pharmaceuticals (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CsMYB308 as a repressive transcription factor inhibits anthocyanin biosynthesis in tea plants.
Hui Zhou, Baoyi Chen, Yue Yang Du, Huan Zhang, Jie Lin Li, Chu Yuan Lin, Yong En Lin, Ling Yun Zhang

Plant Physiol Biochem· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between anti-inflammatory therapies and renal outcomes in patients with established cardiovascular disease or high cardiovascular risks: a meta-analysis of randomised controlled trials.
Wenfeng Yang, Zonglin Li, Chu Lin, Xiaoling Cai, Fang Lv, Linong Ji

Inflammopharmacology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of glucose fluctuation between metformin combined with acarbose or sitagliptin in Chinese patients with type 2 diabetes: A multicenter, randomized, active-controlled, open-label, parallel design clinical trial.
Xiaoling Cai, Suiyuan Hu, Chu Lin, Jing Wu, Junfen Wang, Ling Chen, Lin Nie, Linong Ji

Chin Med J (Engl)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Material basis and mechanism of action of Arisaematis Rhizoma Preparatum in treatment of chronic obstructive pulmonary disease based on animal experiments, UPLC Q-Exactive Orbitrap MS, and network pharmacology].
Lin Chu, Shao-Qing Zhu, Zi-Xuan Yang, Wei Wang, Huan Yang

Zhongguo Zhong Yao Za Zhi· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing CGMap: Characterizing Continuous Glucose Monitoring Data in Patients with Type 2 Diabetes.
Shuzhen Bai, Chu Lin, Xiaoling Cai, Suiyuan Hu, Jing Wu, Ling Chen, Linong Ji

Biomedicines· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting the association between sodium-glucose cotransporter-2 inhibitors and the risk of neoplasm in patients with type 2 diabetes: new insights from an updated systematic review and meta-analysis of randomized controlled trials.
Yiran Wang, Zonglin Li, Chu Lin, Jinyu Zhou, Xiaoling Cai, Linong Ji

Expert Rev Clin Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA.
Mengqing Zhang, Chu Lin, Xiaoling Cai, Ruoyang Jiao, Shuzhen Bai, Zonglin Li, Geling Liu, Xiaolin Yang, Linong Ji

Diabetes Obes Metab· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and external validation of an algorithm for self-identification of risk for microvascular complications in patients with type 1 diabetes.
Wei Liu, Xiaodan Hu, Yayu Fang, Shenda Hong, Yu Zhu, Chu Lin, Xiaoling Cai, Linong Ji

Diabetes Obes Metab· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic syndrome in type 1 diabetes: higher time above range and glycemic variability revealed by continuous glucose monitoring (CGM).
Yayu Fang, Wei Liu, Xiaoling Cai, Yu Zhu, Mingxia Zhang, Chu Lin, Linong Ji

Diabetol Metab Syndr· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Computed Tomography in Predicting Programmed Death Ligand-1 Positivity in Gastric Adenocarcinoma.
Zhi-Hong Yu, Wei-Qin Ma, Ji-Wei Ren, Xu-Ting Zhang, Lin Chu

J Multidiscip Healthc· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the mechanisms of Suzijiangqi Pill in COPD intervention through UPLC Q-Exactive Orbitrap MS, network pharmacology, and animal experiments.
Wei Wang, Shaoqing Zhu, Lin Chu, Yunpeng Zhu, Huan Yang

Nat Prod Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing body composition modifying effects of a glucagon-like peptide 1 receptor-based agonist: A meta-analysis.
Ruoyang Jiao, Chu Lin, Xiaoling Cai, Jingxuan Wang, Yuan Wang, Linong Ji

Diabetes Obes Metab· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials.
Zonglin Li, Chu Lin, Xiaoling Cai, Fang Lv, Wenjia Yang, Linong Ji

Alzheimers Res Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice.
Fang Lv, Xiaoling Cai, Chu Lin, Wenjia Yang, Linong Ji

Pharmaceuticals (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cornus Officinalis Iridoid Glycosides Protect against Chronic Renal Failure in Rats by Activating the Nrf2-antioxidant Pathway.
Aiping Zhao, Yuliang Qiu, Jing Wu, Shangzheng Dai, Chu Lin

Ann Clin Lab Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mulberry Twig Alkaloids Improved the Progression of Metabolic-Associated Fatty Liver Disease in High-Fat Diet-Induced Obese Mice by Regulating the PGC1α/PPARα and KEAP1/NRF2 Pathways.
Mengqing Zhang, Chengcheng Guo, Zonglin Li, Xiaoling Cai, Xin Wen, Chu Lin, Linong Ji

Pharmaceuticals (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis